Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype

Carcinogenesis

Volumn 21, Issue 4, 2000, Pages 607-615

  Delfino, Ralph J ^a   Sinha, Rashmi ^b   Smith, Cynthia ^a   West, John ^c   White, Edward ^d   Lin, Henry J ^e   Liao, Shu Yuan ^a   Gim, Jason S Y ^e   Ma, Hoang L ^e   Butler, John ^a   Anton Culver, Hoda ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Breast Care and Imaging Center of Orange County   (United States)

^d Saddleback Breast Center   (United States)

^e HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AROMATIC AMINE; HETEROCYCLIC AMINE;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; BREAST FIBROADENOMA; BREAST HYPERPLASIA; CANCER RISK; CONTROLLED STUDY; COOKING; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MEAT; MODEL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0034049221     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.4.607     Document Type: Article

References (65)

1. Snyderwine, E.G. (1994) Some perspectives on the nutritional aspects of breast cancer research: food-derived heterocyclic amines as etiologic agents in human mammary cancer. Cancer, 74, 1070-1077.
2. Felton, J.S., Knize, M.G., Shen, N.H., Andresen, B.D., Bjeldanes, L.F. and Hatch, F.T. (1986) Identification of the mutagens in cooked beef. Environ. Health Perspect., 67, 17-24.
3. Gross, G.A. and Gruter, A. (1992) Quantitation of mutagenic/carcinogenic heterocyclic amines in food products. J. Chromatogr., 592, 271-278.
4. Sinha, R., Rothman, N., Brown, E.D., Mark, S.D., Hover, R.N., Caporaso, N.E., Levander, O.A., Knize, M.G., Lang, N.P. and Kadlubar, F.F. (1994) Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome p4501A2 activity in humans. Cancer Res., 54, 6154-6159.
5. Sinha, R., Rothman, N., Salmon, C.P., Knize, M.G., Brown, E.D., Swanson, C.A., Rhodes, D., Rossi, S., Felton, J.S. and Levander, O.A. (1998) Heterocyclic amine content in beef cooked by different methods to varying degrees of doneness and gravy made from meat drippings. Food Chem. Toxicol., 36, 279-287.
6. Sinha, R., Knize, M.G., Salmon, C.P., Brown, E.D., Rhodes, D., Felton, J.S., Levander, O.A. and Rothman, N. (1998) Heterocyclic amine content of pork products by different methods and to varying degrees of doneness. Food Chem. Toxicol, 36, 289-297.
7. Layton, D.W., Bogen, K.T., Knize, M.G., Hatch, F.T., Johnson, V.M. and Felton, J.S. (1995) Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis, 16, 39-52.
8. Kato, T., Migita, H., Ohgaki, H., Sato, S., Takayama, S. and Sugimura, T. (1989) Induction of tumors in the Zymbal gland, oral cavity, colon, skin and mammary gland of F344 rats by a mutagenic compound, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline. Carcinogenesis, 10, 601-603.
9. Ohgaki, H., Takayama, S. and Sugimura, T. (1991) Carcinogenicities of heterocyclic amines and cooked food. Mutat. Res., 259, 399-410.
10. Ito, N., Haseawga, R., Sano, S., Tamano, S., Esumi, H., Takayama, S. and Sugimuri, T. (1991) A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis, 12, 1503-1506.
11. Shirai, T., Tamano, S., Sano, M., Masui, T., Hasegawa, R. and Ito, N. (1993) Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP) in rats: dose response studies. In Adamson, R., Gustafsson, J.A., Ito, N., Nagao, M., Sugimura, T., Wakabayashi, K. and Yamazoe, Y. (eds) Heterocyclic Amines in Cooked Foods: Possible Human Carcinogens. Princeton Scientific Publication Co., Princeton, NJ.
12. Nagao, M., Ushijima, T., Wakabayaski, K., Ochiai, M., Kushida, H., Sugimura, T., Hasegawa, R., Shirai, T. and Nobuyuki, I. (1994) Dietary carcinogens and mammary carcinogenesis: induction of rat mammary carcinomas by administration of heterocyclic amines in cooked foods. Cancer, 74, 1063-1069.
13. Felton, J.S., Kaniez, M.G., Roper, M., Fulz, E., Shen, N.H. and Turteltaub, K.W. (1992) Dosimetry of hydrocyclic amines from cooked meats. Cancer Res., 52 (suppl.), 2103-2107.
14. Ushiyama, H., Wakabayashi, K., Hirose, M., Itoh, H., Sugimura, T. and Nagao, M. (1991) Presence of carcinogenic heterocylic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation. Carcinogenesis, 12, 1417-1422.
15. Hein, D.W. (1988) Acetylator genotype and arylamine-induced carcinogenesis. Biochim. Biophys. Acta, 948, 37-66.
16. Blum, M., Grant, D.M., McBride, O.W., Heim, M. and Meyer, U.A. (1990) Human arylamine N-acetyltransferase genes: isolation, chromosomal localization and functional expression. DNA Cell Biol., 9, 193-203.
17. Vatsis, K.P., Martell, K.J. and Weber, W.W. (1991) Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc. Natl Acad. Sci. USA, 88, 6333-6337.
18. Grant, D.M., Blum, M., Beer, M. and Meyer, U.A. (1991) Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol., 39, 184-191.
19. Ohsako, S. and Deguchi, T. (1990) Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J. Biol. Chem., 265, 4360-4364.
20. Lin, H.J., Han, C.-Y., Lin, B.K. and Hardy.S. (1993) Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 798 Asians, Blacks, Hispanics and Whites: application to metabolic epidemiology. Am. J. Hum. Genet., 52, 827-834.
21. Bell, D.A., Taylor, J.A., Butler, M.A., Stephens, E.A., Wiest, J., Brubaker, L.H., Kadlubar, F.F. and Lucier, G.W. (1993) Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis, 14, 1689-1692.
22. Lin, H.J., Han, C.-Y., Lin, B.K. and Hardy, S. (1994) Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics, 4, 125-134.
23. Hein, D.W., Doll, M.A., Rustan, T.D., Gray, K., Feng, Y., Ferguson, R.J. and Grant, D.M. (1993) Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis, 14, 1633-1638.
24. Bell, D.A., Stephens, E.A., Castranio, T., Umbach, D.M., Watson, M., Deakin, M., Elder, J, Hendrickse, C., Duncan, H. and Strange, R.C. (1995) Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res., 55, 3537-3542.
25. Buller, M.A., Lang, N.P., Young, J.F., Caporaso, N.E., Vineis, P., Hayes, R.B., Teitel, C.H., Massengill, J.P., Lawsen, M.F. and Kadlubar, F.F. (1992) Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics, 2, 16-27.
26. Ilett, K.F., Reeves, P.T., Minchin, R.F., Kinnear, B.F., Watson, H.F. and Kadlubar, F.F. (1991) Distribution of acetyltransferase activities in the intestines of rapid and slow acetylator rabbits. Carcinogenesis, 12, 1465-1469.
27. Turesky, R.J., Lang, N.P., Butler, M.A., Teitel, C.H. and Kadlubar, F.F. (1992) Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis, 12, 1839-1845.
28. Probst, M.R., Blum, M., Fasshauer, I., D'Orazio, D., Meyer, U.A. and Wild, D. (1992) The role of the human acetylation polymorphism in the metabolic activation of the food carcinogen 2-amino-3-methylimidazo [4,5-f]-quinoline (IQ). Carcinogenesis, 13, 713-717.
29. Flammang, T.J., Yamazoe, Y., Guengerich, F.P. and Kadlubar, F.F. (1987) The S-acetyl coenzyme A-dependent metabolic activation of the carcinogen N-hydroxy-2-aininofluorene by human liver cytosol and its relationship to the aromatic amine N-acetyltransferase phenotype. Carcinogenesis, 8, 1967-1970.
30. Paulsen, J.E., Steffensen, I.L., Namork, E., Hein, D.W. and Alexander, J. (1996) Effect of acetylator genotype on 3,2′-climethyl-4-aminobiphenyl induced abberant crypt foci in the colon of hamsters. Carcinogenesis, 17, 459-465.
31. Pfau, W., O'Hare, M.J., Grover, P.L. and Phillips, D.H. (1992) Metabolic activation of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) to DNA binding species in human mammary epithelial cells. Carcinogenesis, 13, 907-909.
32. Baker, L.H., Chin, D.Y. and Wagner, K.V. (1995) Progress in screening for early breast cancer. J. Surg. Oncol., 30, 96-102.
33. Page, D.L. and Anderson, T.J. (1988) Diagnostic Hislopathology of the Breast. Churchill Livingstone. Edinburgh, UK.
34. Page, D.L. and Rogers, L.W. (1992) Combined histolopathologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum. Pathol., 23, 1095-1097.
35. Dupont, W.D., Page, D.L., Parl, F.F., Vnencak-Jones, C.L., Plummer, W.D., Rados, M.S. and Schuyler, P.A. (1994) Long-term risk of breast cancer in women with fibroadenoma. N. Engl. J. Med., 331, 10-15.
36. Carter, C.L., Corle, D.K. and Micozzi, M.S. (1988) A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am. J. Epidemiol., 128, 467-477.
37. London, S.J., Connolly, J.L. and Schnitt, S.J. (1992) A prospective study of benign breast disease and the risk of breast cancer. J. Am. Med. Assoc., 267, 941-944.
38. Dupont, W.D., Parl, F.F, Hartmann, W.H., Brinton, L.A., Winfield, A.C., Worrell, J.A., Schuyler, P.A. and Plummer, W.D. (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer, 71, 1268-1265.
39. Bodian, C.A., Perzin, K.H., Lattes, R., Hoffmann, P. and Abernathy, T.C. (1993) Prognostic significance of benign proliferative breast disease. Cancer, 71, 3896-3907.
40. Krieger, N. and Hiatt, R.A. (1992) Risk of breast cancer after benign breast diseases: variation by histologic type, degree of atypia, age of biopsy and length of follow-up. Am. J. Epidemiol., 135, 619-631.
41. Bodian, C.A. (1993) Benign breast diseases, carcinoma in-situ and breast cancer risk. Epidemiol. Rev., 15, 177-187
42. Geever, R.F., Wilson, L.B., Nallaseth, F.S., Milner, P.F., Bittner, M. and Wilson, J.T. (1981) Direct identification of sickle cell anemia by blot hybridization. Proc. Natl Acad. Sci. USA, 78, 5081-5085.
43. Bell, G.I., Karam, J.H. and Rutter, W.J. (1981) Polymorphic DNA region adjacent to the 5′ end of the human insulin gene. Proc. Natl Acad. Sci. USA, 78, 5759-5763.
44. Vatsis, K.P., Weber, W. W., Bell, D.A., Dupret, J.-M., Evans, D.A.P., Grant, D.M., Hein, F.D.W., Lin, H.J., Meyer, U.A., Relling, M.V., Sim, E., Suzuki, T. and Yamazoe, Y. (1995) Nomenclature for N-acetyltransferases. Pharmacogenetics, 5, 1-17.
45. Block, G., Woods, M. and Potosky, A. (1990) Validation of a self-administered diet history questionnaire using multiple diet records. J. Clin. Epidemiol., 43, 1327-1335.
46. Block, G., Coyl, L.M., Hartman, A.M. and Scoppa, S.M. (1994) Revision of dietary analysis software for the Health Habits and History Questionnaire. Am. J. Epidemiol., 139, 1190-1196.
47. Sinha, R., Rothman, N., Brown, E.D., Salmon, C.P., Knize, M.G., Swanson, C.A., Rossi, S.C., Mark, S.D., Levander, O.A. and Felton, J.S. (1995) High concentrations of the carcinogen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) occur in chicken but are dependent on the cooking method. Cancer Res., 55, 4516-4519.
48. ® Software: Changes and Enhancements through Release 6.11. SAS Institute Inc., Cary, NC, pp. 381-490.
49. Agúndez, J.A., Ladero, J.M., Olivera, M., Abildúa, R., Roman, J.M. and Brenítez, J. (1995) Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients. Oncology, 52, 7-11.
50. Ambrosone, C.B., Freudenheim, L., Graham, S., Marshall, J.R., Vena, J.E., Brasure, J.R., Michalek, A.M., Laughlin, R., Nemoto, T., Gillenwater, K.A., Harrington, A.M. and Shields, P.G. (1996) Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms and breast cancer risk. J. Am. Med. Assoc., 276, 1494-1501.
51. Humer, D.J., Hankinson, S.E., Hough, H., Gertig, D.M., Garcia-Closas, M., Spiegelman, D., Manson, J.E., Colditz, G.A., Willett, W.C., Speizer, F.E. and Kelsey, K. (1997) A prospective study of NAT2 acetylation genotype, cigarette smoking and risk of breast cancer. Carcinogenesis, 18, 2127-2132.
52. Millikan, R.C., Pittman, G.S., Newman, B., Tse, C.-K.J., Selmin, O., Rockhill, B., Savitz, D., Moorman, P.G. and Bell, D.A. (1998) Cigarette smoking, N-acetyltransferases 1 and 2 and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 7, 371-378.
53. Sadrieh, N., Davis, C.D. and Snyderwine, E.G. (1996) N-acetyltransferase expression and metabolic activiation of the food-derived heterocyclic amines in the human mammary gland. Cancer Res., 56, 2683-2687.
54. Zheng, W., Gustafson, D.R., Sinha, R., Cerhan, J.R., Moore, D., Hong, C.-P., Anderson, K.E., Kushi, L.H., Sellers, T.A. and Folsom, A.R. (1998) Well-done meat intake and the risk of breast cancer. J. Natl Cancer Inst., 90, 1724-1729.
55. Gertig, D.M., Hankinson, S.E., Hough, H., Spiegelman, D., Colditz, G.A., Willett, W.C., Kelsey, K.T. and Hunter, D.J. (1999) N-acetyl transferase 2 genotypes, meat and breast cancer risk. Int. J. Cancer, 30, 13-17.
56. Ambrosone, C.B., Freudenheim, J.L., Sinha, R., Graham, S., Marshall, J.R., Vena, J.E., Laughlin, R., Nemoto, T. and Shields, P.G. (1998) Breast cancer risk, meat consumption, N-acetyltransferase (NAT2) genetic polymorphisms. Int. J. Cancer, 75, 825-830.
57. Egan, K.M. and Giovannucci, E. (1998) Dietary mutagens and the risk of breast cancer. J. Natl Cancer Inst., 90, 1729-1731.
58. Holmes, M.D., Hunter, D.J., Colditz, G.A., Stampfer, M.J., Hankinson, S.E., Speizer, F.E., Rosner, B. and Willett, W.C. (1999) Association of dietary intake of fat and fatty acids with risk of breast cancer. J. Am. Med. Assoc., 281, 914-920.
59. Philip, P.A., Rogers, H.J., Millis, R.R., Rubens, R.D. and Cartwright, R.A. (1987) Acetylator status and its relationship to breast cancer and other diseases of the breast. Eur. J. Cancer Clin. Oncol., 23, 1701-1706.
60. Foerster, S.B., Kizer, K.W., Disogra, L.K., Bal, D.G., Krieg, B.F. and Bunch, K.L. (1995) California's '5 a day - for better health!' campaign: an innovative population-based effort to effect large-scale dietary change. Am. J. Prev. Med., 11, 124-131.
61. Probst-Hench, N.M., Sinha, R., Longnecker, M.P., Witte, J.S., Ingles, S.A., Frankl, H.D., Lee, E.R. and Haile, R.W. (1997) Meat preparation and colorectal adenomas in a large sigmoidoscopy-based case-control study in California (United States). Cancer Causes Control, 8, 175-183.
62. Ward, M.H., Sinha, R., Heineman, E.F., Rothman, N., Markin, R., Weisenburger, D.D., Correa, P. and Zahm, S.H. (1997) Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int. J. Cancer, 71, 14-19.
63. Augustsson, K., Skog, K., Jägerstad, M., Dickman, P.W. and Steineck, G. (1999) Dietary heterocyclic amines and cancer of the colon, rectum, bladder and kidney: a population-based study. Lancet, 353, 703-707.
64. Helzlsouer, K.J., Selmin, O., Huang, H.-Y., Strickland, P.T., Hoffman, S., Alberg, A.J., Watson, M., Comstock, G.W. and Bell, D. (1998) Association between Glutathione S-Transferase M1, P1, T1 genetic polymorphisms and development of breast cancer. J. Natl Cancer Inst., 90, 512-518.
65. Roberts-Thomson, S.J. and Snyderwine, E.G. (1997) Effect of dietary fat on codon 12 and 13 Ha-ras gene mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary gland tumors. Mol. Carciriag., 20, 348-354.